… means of drug delivery system, to overcome cancer treatment failure, … One big benefit of this
NP is its capacity to resolve multidrug … Paclitaxel-loaded PBCA NPs were formulated through …

… Methods: This article aims to review the effectiveness of PBCA as a drug delivery system
in … of overcoming multi-drug resistance (MDR) could be the absorption of nanoparticles (NPs) …

… synthesized and purified easily and are able to overcome multidrug resistance (MDR) [8]. …
drug delivery systems [36]. Moreover, using biodegradable materials for nanoparticle …

… The particles could overcome multi-drug resistance [20]. … a candidate carrier material
for drug delivery systems. … delivery systems found among various types of poly-alkyl-cyanoacrylate …

… In this work, magnetite nanoparticles were coated with poly(butylcyanoacrylate) (PBCA) …
controlled drug delivery. The average diameter of magnetite and core–shell nanoparticles was …

… the accumulation of nanoparticles at tumor sites via enhanced permeability and retention
(EPR) effect [Citation32]. In the case of oral drug delivery systems, nanoparticles below 200 nm …

… to overcome multidrug … nanoparticles as a drug delivery system, affecting the pharmacokinetics
of the particles in the body [44]. In the current study, the morphology of the nanoparticles …

… a delivery system … multidrug resistance (MDR) in human ovarian resistant cells (A2780/T)
and investigated its possible mechanism. They prepared paclitaxel-loaded PBCA nanoparticles …

… based delivery systems have been tested for overcoming this … PACA NPs is the ability to
overcome multidrug resistance (MDR) [… Also, 1, 3β-glucan-anchored paclitaxel-loaded CS cross-…

… experimental conditions for drug delivery systems, which optimize … the poly(butyl-2-cyanoacrylate)
nanoparticles preparation. … Paeonol-loaded poly(n-butylcyanoacrylate) nanocapsules …